Literature DB >> 9041146

H19 in normal development and neoplasia.

L H Looijenga1, A J Verkerk, N De Groot, A A Hochberg, J W Oosterhuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9041146     DOI： 10.1002/(SICI)1098-2795(199703)46:3<419::AID-MRD22>3.0.CO;2-S

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN： 1040-452X            Impact factor:   2.609


× No keyword cloud information.
  5 in total

1.  Altered expression of members of the IGF-axis in hepatoblastomas.

Authors:  S G Gray; T Eriksson; C Ekström; S Holm; D von Schweinitz; P Kogner; B Sandstedt; T Pietsch; T J Ekström
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

2.  Human pluripotent embryonal carcinoma NTERA2 cl.D1 cells maintain their typical morphology in an angiomyogenic medium.

Authors:  Pedro D Simões; Teresa Ramos
Journal:  J Negat Results Biomed       Date:  2007-04-18

3.  Overexpression of primary microRNA 221/222 in acute myeloid leukemia.

Authors:  Anna Rommer; Katarina Steinleitner; Hubert Hackl; Christine Schneckenleithner; Maria Engelmann; Marcel Scheideler; Irena Vlatkovic; Robert Kralovics; Sabine Cerny-Reiterer; Peter Valent; Heinz Sill; Rotraud Wieser
Journal:  BMC Cancer       Date:  2013-07-29       Impact factor: 4.430

4.  A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases.

Authors:  Xiaofei Yang; Lin Gao; Xingli Guo; Xinghua Shi; Hao Wu; Fei Song; Bingbo Wang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

5.  Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin.

Authors:  Bailing Chen; Miaomiao Yu; Qingshan Chang; Yongju Lu; Chitra Thakur; Danjun Ma; Zhenping Yi; Fei Chen
Journal:  Oncotarget       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.